At this time, posts about Naivek are rapidly increasing on portals and stock communities, with foreign investors tentatively reported to have net purchased 3,165 shares today. Naivek is known as a manufacturer of biomaterials for tissue regeneration and oral health products.
As of 1:30 PM on the 25th, Naivek's stock price is 38,200 KRW, up 0.79% from the previous day, with a trading volume of 301,434 shares, which is about 40.84% of the 5-day average trading volume. On February 24, Naivek was a market topic due to the news of 'European CRO validation for pulmonary fibrosis treatment.'
In addition to Naivek, posts by investors are also surging for Yeonghwa Metal (012280), Genie Music (043610), and Digital Optic (106520).
※Source: AI Investment Assistant AI Lassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
